Northstar Neuroscience
This article was originally published in The Gray Sheet
Executive Summary
Seattle firm announces completion of enrollment May 31 in the 174-patient, 21-center randomized pivotal trial of its Renova-ST cortical stimulation system for treatment of post-stroke motor recovery. The EVEREST trial compares improvement in hand and arm function in chronic stroke survivors treated with physical therapy alone versus those treated with physical therapy plus stimulation of the cerebral cortex with Renova-ST. Northstar hopes to file a PMA for the device by the end of 2007 (1"The Gray Sheet" July 31, 2006, p. 13)...